The rise in Venus Remedies share price came after the company announced the renewal of its European GMP certification by ...

Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.

Pharma major Venus Remedies on Tuesday said it has secured renewal of European Good Manufacturing Practices (EU-GMP) certification by Infarmed, the National Authority of Medicines and Health Products ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, ...

Venues remedies rallied 5.30% to Rs 310.95 after the company successfully renewed its European good manufacturing practices (GMP) certification by infarmed, the national health authority of Medicines ...

Aurora Cannabis (ACB) announces the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed.

Canadian shares may open flat or with a slightly negative bias on Thursday, tracking weak crude oil prices and amid concerns about ...

HYTN will endeavour to amend its licenses and/or certificates, establish a stability program, and implement GMP-compliant processes tailored for vape cartridge production.

The certification covers the company’s manufacturing facility for cephalosporin, carbapenem, and lyophilized injectable ...

Curaleaf Holdings down 68% in a year, with 66 dispensaries in Florida. Q324 showed in-line results and international growth.

SOMAÍ Pharmaceuticals partnered with Pacific Cannovation Company Limited (PACCAN) to transform Thailand into a global hub for high-quality medicinal cannabis ...

Leveraging HYTN’s GMP-certified facility and expertise in quality system development, SNDL will provide specialized equipment, cannabis consumables, and the required capital to meet stringent ...